ImmunityBio

    OverviewSuggest Edit

    ImmunityBio (formerly NantCell) is an immunotherapy company focusing on cell-based treatments against cancer and infectious diseases. It develops combinations of chemo-immune sensitizers, cell therapies, cytokines, vaccines, neoepitopes, and monoclonal antibody immunotherapies.
    TypePrivate
    Founded2014
    HQCulver City, CA, US
    Websiteimmunitybio.com
    Employee Ratings3.2

    Latest Updates

    Employees (est.) (Mar 2021)178(+2%)
    Cybersecurity ratingAMore
    Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
    Banner background

    Key People/Management at ImmunityBio

    David Sachs

    David Sachs

    Chief Financial Officer
    Patrick Soon-Shiong

    Patrick Soon-Shiong

    Executive Chairman
    Leonard S. Sender

    Leonard S. Sender

    Chief Operating Officer
    Fabio Benedetti

    Fabio Benedetti

    Chief Strategy Officer
    Sarah Singleton

    Sarah Singleton

    Chief Communications Officer
    Barry Simon

    Barry Simon

    Chief Corporate Affairs Officer and Director
    Show more

    ImmunityBio Office Locations

    ImmunityBio has an office in Culver City
    Culver City, CA, US (HQ)
    9920 Jefferson Blvd
    Show all (1)

    ImmunityBio Financials and Metrics

    Summary Metrics

    Founding Date

    2014

    ImmunityBio Cybersecurity Score

    Cybersecurity ratingPremium dataset

    A

    91/100

    SecurityScorecard logo

    ImmunityBio Online and Social Media Presence

    Embed Graph

    ImmunityBio News and Updates

    Thinking about buying stock in Grupo Televisa, Phunware, Immunitybio, Flexion Therapeutics, or Amicus Therapeutics?

    NEW YORK, April 14, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for TV, PHUN, IBRX, FLXN, and FOLD. To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link....

    ImmunityBio Frequently Asked Questions

    • When was ImmunityBio founded?

      ImmunityBio was founded in 2014.

    • Who are ImmunityBio key executives?

      ImmunityBio's key executives are David Sachs, Patrick Soon-Shiong and Leonard S. Sender.

    • How many employees does ImmunityBio have?

      ImmunityBio has 178 employees.

    • Who are ImmunityBio competitors?

      Competitors of ImmunityBio include Merz North America, Laboratorios Bago and Libbs Farmaceutica.

    • Where is ImmunityBio headquarters?

      ImmunityBio headquarters is located at 9920 Jefferson Blvd, Culver City.

    • Where are ImmunityBio offices?

      ImmunityBio has an office in Culver City.

    • How many offices does ImmunityBio have?

      ImmunityBio has 1 office.